ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug.

Vatsal Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.